InsiderTrades.com logo
Media Is Mocking Elon, But Wait Until They See This Demo
From Brownstone Research   |   Ad
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
Click here to watch this demo and decide for yourself.

IGC Insider Trading

Insider Ownership Percentage: 31.48%
Insider Buying (Last 12 Months): $199,999.90
Insider Selling (Last 12 Months): $0.00

IGC Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at IGC Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

IGC Pharma Share Price & Price History

Current Price: $0.37
Price Change: +0.30 (1.20%)
As of 12/9/2024 01:00 AM ET

This chart shows the closing price history over time for IGC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
First JFK… next Elon?
From Porter & Company   |   Ad
Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.
I share with you in this special investigative documentary.

IGC Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/25/2024James P MoranDirectorBuy588,235$0.34$199,999.90942,402View SEC Filing Icon  
See Full Table
Elon Musk’s chilling warning for humanity
From The Freeport Society   |   Ad
The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.
Go here to see why.

SEC Filings (Institutional Ownership Changes) for IGC Pharma (NYSEMKT:IGC)

3.87% of IGC Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

IGC Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/20/2024Virtu Financial LLC123,060$53K0.0%+164.7%0.159%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC562,969$0.24M0.0%+31.0%0.744%Search for SEC Filing on Google Icon
10/29/2024Fullcircle Wealth LLC103,443$42K0.0%N/A0.137%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
Read More on IGC Pharma

Today's Range

Now: $0.37
Low: $0.35
High: $0.40

50 Day Range

MA: $0.38
Low: $0.33
High: $0.41

52 Week Range

Now: $0.37

Volume

804,059 shs

Average Volume

370,646 shs

Market Capitalization

$28.53 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29

Who are the company insiders with the largest holdings of IGC Pharma?

IGC Pharma's top insider investors include:
  1. James P Moran (Director)
Learn More about top insider investors at IGC Pharma.

Who are the major institutional investors of IGC Pharma?

IGC Pharma's top institutional shareholders include:
  1. Geode Capital Management LLC — 0.74%
  2. Virtu Financial LLC — 0.16%
  3. Fullcircle Wealth LLC — 0.14%
Learn More about top institutional investors of IGC Pharma stock.

Which institutional investors are buying IGC Pharma stock?

During the previous quarter, IGC stock was acquired by institutional investors including:
  1. Geode Capital Management LLC
  2. Fullcircle Wealth LLC
  3. Virtu Financial LLC
Media Is Mocking Elon, But Wait Until They See This Demo
From Brownstone Research   |   Ad
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
Click here to watch this demo and decide for yourself.